Our news and updates

Highlights:

  • January 2024: launch of the new technical platform CELL PHENOTYPING Platform
  • March 2024: launch of Salutederm, innovative project aimed at developing advanced solutions for the precise diagnosis and targeted treatment of skin lesions. Find more

Highlights:

Highlights:

Highlights:

  • January 2021: Silvia Biggi appointed as Chief Scientific Officer

Neuro-Zone will be glad to meet you:

Highlights:

  • June 2020: Neuro-Zone and BiomimX entered into a commecial collaboration agreement - Press Release

Neuro-Zone will be glad to meet you:

Highlights:

Neuro-Zone will be glad to meet you:

Highlights:

  • June 2018: Neuro-Zone as consortium partner in NeOn, a project focused on the creation of an innovative R&D platform for the discovery and development of new treatments to counteract CNS diseases and cancer. Press Release | Regione Lombardia | Sole24Ore
  • April 2018: Neuro-Zone launches MITOS Platform, Mitochondrial Integrity, Toxicity and Oxidative Stress, an analytical platform dedicated to the characterization of mitochondrial function and dysfunction.

Neuro-Zone will be glad to meet you:

Highlights:

  • January 2016: Neuro-Zone announces MicroTISSUE- The Multiparametric Microfluidic Platform for Phenotypic screening of the Extracellular Microenvironment.
  • March 2016: Neuro-Zone launches new Neuropathic Pain Pathology Platform for screening and Drug Discovery, within the MicroTISSUE Platform Program.
  • September 2016: Neuro-Zone launches new Cardiogenic Shock and Septic Shock Platform for screening and Drug Discovery, within the MicroTISSUE Platform Program.

Neuro-Zone will be glad to meet you:

Highlights:

  • In December 2015: Neuro-Zone is invited to present at “Astra Zeneca Marketplace External Day Insights” in Molndal, Sweden.
  • Neuro-Zone will be glad to meet you:

    Neuro-Zone will be glad to meet you: